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Abstract We investigated the effect of C-reactive
protein (CRP) and sodium azide (NaN3) on endo-
thelial Cx43 gap junctions. Human aortic endothelial
cells (HAEC) were treated with (a) detoxified CRP,
(b) detoxified dialyzed CRP, (c) detoxified dialyzed
CRP plus NaN3, (d) NaN3, or (e) dialyzed NaN3.
The concentration of CRP in all preparations was
fixed to 25 μg/ml and that of NaN3 in the
preparations of (c) to (e) was equivalent to that
contained in the 25 μg/ml CRP purchased commer-
cially. The results showed that both the expression of
Cx43 protein and gap junctional communication
function post-48-h incubation were reduced and
inhibited by the detoxified CRP, NaN3, or detoxified
dialyzed CRP plus NaN3, but not by the detoxified
dialyzed CRP or dialyzed NaN3. Reverse
transcription-polymerase chain reaction analysis of
cells treated for 72 h also showed a pattern of
transcriptional regulation essentially the same as that
for the proteins. We concluded that CRP does not
have a significant effect on Cx43 gap junctions of
HAEC, but NaN3 inhibited the viability of cells and
downregulate their junctions.
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Abbreviation
Cx43 Connexin43
HAEC Human aortic endothelial cells
NaN3 Sodium azide
Introduction
Atherosclerosis is an inflammatory process occurring
in the arterial wall accompanied by a variety of
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systemic responses. C-reactive protein (CRP), a
pentameric protein (molecular weight 118 kDa) pro-
duced in the liver and released into circulation, is a
sensitive maker of inflammation (Volanakis 2001;
Verma et al. 2004). Clinical studies have shown that
the level of CRP is a useful predictor of atheroscle-
rotic cardiovascular disease (Ridker et al. 1998, 2002;
Abraham et al. 2007). Laboratory examination also
demonstrated that this protein has a diversity of
effects on the vascular wall, including alteration of
endothelial function (Clapp et al. 2005; Yaron et al.
2006). Maintenance of the functional integrity of
vascular endothelium requires coordination of the
activities of individual cells via gap junctions (Yeh et
al. 1998; Simon and McWhorter 2002). Previous
studies showed that endothelial gap junctions, mainly
made of Cx43, Cx40, and Cx37, were downregulated
at the presence of risk factors for atherosclerosis
(Davignon and Ganz 2004), which are known to be
associated with endothelial dysfunction. Since the
level of CRP is elevated in many clinical conditions
associated with endothelial dysfunction (Nystrom et
al. 2005; Chung et al. 2007), this raises a possibility
that CRP has a direct effect on endothelial gap
junctions. Moreover, CRP might participate in vascu-
lar pathogenesis by impairing NO production (Jialal
et al. 2004), increasing the activity of plasminogen
activator inhibitor 1 (Nakakuki et al. 2005) and tissue
plasminogen activator (Singh et al. 2005), and
upregulating the expression levels of chemoattractant
molecules and interleukins (Pasceri et al. 2000).
On the other hand, recent studies indicated that
sodium azide (NaN3), a preservative for commercially
available human recombinant CRP generated in
Escherichia coli, has toxic effects on endothelial cells
(Liu et al. 2005). In addition, different conformations
of CRP have been reported to possess differential
effects (Khreiss et al. 2004; Verma et al. 2004;
Devaraj et al. 2006). Although Cx43 transcripts had
been found changed by human recombinant CRP in a
microarray analysis (Wang et al. 2005), the expression
level of protein and the communication function
remained unclear. In addition, the effects of different
conformations of CRP as well as the role of NaN3 or
Cx43 require clarification. To these ends, we therefore
examined the response of gap junctions to pentameric
CRP and NaN3 in cultured human aortic endothelial
cells (HAEC). Our previous studies have shown that
Cx43 is by far the predominant gap junction protein
expressed in HAEC (Yeh et al. 2006; Wang et al.
2008).
Materials and methods
CRP preparation
Recombinant human C-reactive protein from Calbio-
chem (San Diego, CA, USA) with the same lot
number (B68550) was used in this study. The
commercial CRP, containing 0.05% NaN3 originally,
was first flowed through the Detoxi-Gel endotoxin
removing column (Pierce, Rockford, IL, USA) to
remove lipopolysaccharides (LPS) contamination and
then dialyzed against storage buffer (20 mM Tris-
HCl, pH7.5, 140 mM NaCl, 2 mM CaCl2) with
2,000-fold sample volume under 4°C for 24 h, during
which period buffers were exchanged at 4 and 8 h.
After these detoxification procedures, CRPs from
different preparations were quantitated with modified
Lowry’s method (DC protein assay kit, Bio-Rad,
Hercules, CA, USA). The content of LPS was
evaluated by QCL-1000 endotoxin detection kit
(Cambrex, Walkersville, MD, USA) and the concen-
tration of LPS in detoxified CRP was less than
0.1 EU/ml. The purity and integrity of CRP was
verified by sodium dodecyl sulfate (SDS) polyacryl-
amide gel electrophoresis and the conformational
change of CRP was investigated by native gel
electrophoresis as previous described (Macintyre et
al. 1994). NaN3 was purchased from Merck (Darm-
stadt, Germany) and NaN3 solution dialyzed against
CRP storage buffer was used as a control.
Cell culture and CRP treatment
Human aortic endothelial cells (Cascade Biologics,
Portland, OR, USA) were maintained in medium 200
with low serum growth supplement (named complete
medium; Cascade Biologics). The culture was seeded
in 1% gelatin-coated plastic ware and maintained in
37°C incubator under a humidified 95% air and 5%
CO2 atmosphere. To conduct treatment experiments,
HAEC were grown in complete medium 200 and
serially passaged until they reached passage 8. The
seeding density is 20,000/cm2. After various periods
of treatment, according to the experimental protocols,
cells were processed for Western blotting, reverse
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transcription-polymerase chain reaction (RT-PCR),
functional analysis of gap junctional communication,
and cell biology analysis.
RT-PCR
Total RNA from HAEC were extracted using
RNeasy Plus mini kit (Qiagen, Hilden, Germany).
One microgram of RNA was applied to the
reaction of reverse transcription using SuperScript
First-Strand Synthesis System kit (Invitrogen,
Carlsbad, CA, USA). One microliter of the RT
products were used for semiquantitative PCR
amplification in a final volume of 10 μl containing
specific primers for Cx43, vascular endothelial
growth factor receptor 1 (Flt-1), vascular endothe-
lial growth factor receptor 2 (KDR), vascular
endothelial growth factor (VEGF), angiopoietin 1
(Ang-1), angiopoietin 2 (Ang-2), plasminogen
activator inhibitor-1 (PAI-1), endothelial nitric
oxide synthase (eNOS), vascular cell adhesion
molecule (VCAM), intercellular adhesion molecule
(ICAM), P-selectin (P-Sel), and glyseraldehyde-3-
phosphate dehydrogenase. The sequence of primers
were listed: Cx43 (sense: 5′-CTC AGC AAC CTG
GTT GTG AA-3′, antisense: 5′-TCG CCA GTA
ACC AGC TTG TA-3′), Flt-1 (sense: 5′-AGC
AAG TGG GAG TTT GC-3′, antisense: 5′-AGG
TCC CGA TGA ATG C-3′), KDR (sense: 5′-GGA
CCT GGC GGC ACG AAA TA-3′, antisense: 5′-
AGG CCG GCT CTT TCG CTT AC-3′), VEGF
(sense: 5′-CTC TAC CTC CAC CAT GCC AA-3′,
antisense: 5′-GCA TGG TGA TGT TGG ACT CC-
3′), Ang-1 (sense: 5′-TAT GCC AGA ACC CAA
AAA GG-3′, antisense: 5′-GCT CTG TTT TCC
TGC TGT CC-3′), Ang-2 (sense: 5′-GGA TCT
GGG GAG AGA GGA AC-3′, antisense: 5′-CTC
TGC ACC GAG TCA TCG TA-3′), PAI-1 (sense:
5′-TCT CAG GAA GTC CAG CCA CT-3′,
antisense: 5′-ACC CTC TGG CTG GTA GGT
TT-3′), eNOS (sense: 5′-AAG ACA TTT TCG
GGC TCA C-3′, antisense: 5′-GGC ACT TTA
GTA GTT CTC C-3′), VCAM (sense: 5′-ACC
CTC CCA GGC ACA CAC AG-3′, antisense: 5′-
GTA AGT CTA TCT CCA GCC TGT C-3′),
ICAM (sense: 5′-CAG TGA CCA TCT ACA GCT
TTC CGC -3′, antisense: 5′-GCT GCT ACC ACA
GTG ATG ATG ACA A-3′), P-Sel (sense: 5′-ACA
AAA GCA TAC TCA TGG AA-3′, antisense: 5′-
CTG GCA GGA GGC TGT GTA ACA-3′), and
β-actin (sense: 5′-TCC TGT GGC ATC CAC
GAA ACT-3′, antisense: 5′-GAA GCA TTT GCG
GTG GAC GAT-3′). PCR was performed at 94°C
for 5 min, followed by amplification cycles of 94°C
for 30 s, 60°C for 30 s, 72°C for 30 s, and
finally 72°C for 10 min. Amplified products were
analyzed by running through 2% (w/v) agarose gels
stained with ethidium bromide. The images were
captured and quantified using ImageMaster TotalLab
software (AmershamPharmacia Biotech, Sunnyvale,
CA, USA). For real-time PCR analysis, endothelial
cDNA were amplified with primers specific for Cx43
(sense: 5′-CCT CTC GCC TAT GTC TCC TC-3′,
antisense: 5′-GCT CAC TTG CTT GCT TGT TG-3′),
Cx37 (sense: 5′-CGT AGA GCG TCA GAT GGC-3′,
antisense: 5′-GCA CAC TGG CGA CAT AGG-3′),
Cx40 (sense: 5′-TCA ATC CCT TCA GCA ATA
ATA TG-3′, antisense: 5′-GTG ACC TGG TGA
GAC TCC-3′), and interleukin 8 (sense: 5′-CCA
CTG TGC CTT GGT TTC-3′, antisense: 5′-TCT
TGC ACA AAT ATT TGA TGC-3′) using iQTM
SYBR Green Supermix reagent and detected with
iQTM Single Color Real-Time PCR Detector System
(all from Bio-Rad, Hercules, CA, USA). Relative
mRNA leve l s were normal i zed wi th the
corresponding levels of β-actin. At least three
independent experiments were conducted for
analysis.
Western blot
To identify the conformation of CRP, both basic-
native gel and SDS gel were used (Macintyre et al.
1994). Aliquots of purified CRP were mixed with five
times loading buffer (0.1 M Tris-HCl, pH6.8, 50%
glycerol, 0.01% bromophenol blue) and resolved on
the 7.5% polyacrylamide gels (0.366 M Tris-HCl,
pH8.9) with 3% stacking gels (0.125 M Tris-HCl,
pH8.9). The running buffer was 50 mM Tris-HCl, pH
8.9, and 0.38 M glycine and gels were run at 120 V
for 60–70 min. After electrophoresis, gels were
stained with Blue Bandit reagent (Amresco, Solon,
OH, USA).
After the treatment procedure, HAEC were
washed and lysed with SB-20 buffer (0.2 g/ml
SDS, 10 mM ethylenediaminetetraacetic acid,
100 mM Tris-HCl, pH6.8). Protein concentrations
were determined with modified Lowry’s method.
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Aliquots of cell lysates were loaded into 10%
SDS-polyacrylamide gels, electrophoresed, and
transblotted onto polyvinylidene fluoride mem-
branes (Amersham). The blots were blocked with
10% bovine serum albumin for 1 h and detected
with primary antibodies specific for Cx43 (BD,
Paterson, NJ, USA). The blots were further
incubated with alkaline phosphatase-conjugated
secondary antibodies for 1 h at room temperature.
Immunoreactivity was visualized using CDP-star
system (Roche, Florence, SC, USA) according to
the manufacturer’s instruction. The radiographs
were subjected to TotalLab software. To normalize
the expression level, blots were stripped with
stripping buffer (20 mg/ml SDS, 100 mM 2-
mercaptoethanol, 93.75 mM Tris-HCl, pH6.8) at
56°C and incubated with β-actin (Abcam) anti-
body as internal control.
Functional assay of gap junctional communication
The function of cell–cell coupling between the
transfected cells was assessed using the scrape
loading (el-Fouly et al. 1987). For the former
analysis, cells in 35 mm culture dish was scraped
with a surgical blade followed by addition of lucifer
yellow/rhodamine dextran (Invitrogen) mixture and
incubated at room temperature for 2 min. Cells were
then carefully washed and replaced for fresh medi-
um. After 5 min incubation, cells were fixed with 1%
paraformaldehyde and examined. The distance be-
tween the middle scrape line stained with rhodamine
dextran and the bilateral edges of lucifer yellow
transfer was measured and compared between
experiments. At least three independent experiments
with each dish scraped 3 lines were conducted for
each treatment.
Cell biology analysis
To analyze the biological effects of NaN3 and CRP,
the cell viability and angiogenic factor were exam-
ined. Cell viability was measured using the 3(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide (MTT) assay. HAEC were seeded onto
24-well plates. After the treatment at indicated time,
medium was replaced with MTT-containing medium
(0.5 mg/ml) and cells were incubated for 4 h at 37°C.
Fig. 1 Representative
electrophoretic gels and
real-time PCR analysis of
CRP. See text for details. a
Denaturing gel. b Native
gels. Each lane was loaded
with 2 μg CRP. Unpro
unprocessed CRP, CRP/Det
CRP through detoxification
column. CRP/Det/Dia CRP
through detoxification
column and dialysis. mCRP
and pCRP indicate the
monomeric and pentameric
form of CRP, respectively.
The electrophoresis front
(bromophenol blue) in each
gel was indicated by an
arrow. c HAEC treated with
CRP through detoxification
column and dialysis at a
concentration of 25 μg/ml
exhibit upregulation of IL-8
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The cells were lysed with isopropanol–HCl solution
and subject to absorbance measurement at 540 nm
with 630 nm reference. At least three independent
experiments were conducted for each group of cells.
Data analysis
Data are expressed as mean ± standard deviation.
Analysis was conducted using one way analysis of
variance or Student’s t test. When p value <0.05, it is
considered statistically significant.
Results
The purity and conformation of CRP from different
purification procedures were determined using elec-
trophoresis, as shown in Fig. 1, in which both
detoxified and detoxified dialyzed CRP had the same
purity and molecular weight as the native form. Real-
time PCR analysis showed that detoxified dialyzed
CRP was capable of increasing the expression level of
interleukin (IL)-8 (Fig. 1c), as previously described
(Devaraj et al. 2004).
Fig. 2 Cell morphology
and viability. a–k Phase
contrast images of HAEC
treated with different prepa-
rations of CRP and NaN3.
The concentrations and
preparations are indicated at
the top of each image. The
histogram shows that all
cells with the morphological
changes are less viable and
almost die by 72 h. Images
were taken at 48 h in a–f
and at 72 h in g–k. See
text for details. Abbrevia-
tions are the same as in
Fig. 1. Bar, 50 μm.
Compared to the control,
*p<0.05; #p<0.01
Cell Biol Toxicol (2010) 26:153–163 157
Cells treated with detoxified CRP underwent a
dramatic morphological change (Fig. 2). At the
concentration of 25 μg/ml, the cells gradually become
round in shape and the borders were retracted by 48 h
of treatment (Fig. 2a). However, cells treated with
detoxified dialyzed CRP for 48 h, either at the
concentration of 25 (Fig. 2b) or 50 μg/ml (Fig. 2c),
did not have such changes. In fact, they maintained
the same cobble stone-like appearance as that of the
control (Fig. 2d). To understand if the morphological
effects of detoxified CRP were due to the presence of
NaN3, cells were treated with 200 μM NaN3, the dose
of which is equivalent to that contained in 25 μg/ml
detoxified CRP. The results showed that the cells
underwent the same morphological change as seen
with detoxified CRP (Fig. 2e). Such changes were
unseen in cells treated with dialyzed NaN3 for 48
(Fig. 2f) or 72 h (Fig. 2g). Further evidence that NaN3
caused the morphologic changes was provided in cells
treated with detoxified dialyzed CRP for 72 h, in
which addition of NaN3 resumed the dramatic
changes (Fig. 2h), in contrast to the cobble stone-
like appearance of cells treated with detoxified
dialyzed CRP for the same period (Fig. 2i). Cells
treated with detoxified CRP (Fig. 2j) underwent the
same morphological change as those with NaN3
(Fig. 2k) for the same period of 72 h. The
morphological changes were consistent with the
results of MTT assay (Fig. 2, histogram), which
showed a reduced cell viability in those treated with
either detoxified CRP or undialyzed NaN3.
Regarding Cx43 protein, after treatment with
detoxified CRP for 24 h, the expression of Cx43
protein was reduced in a dose-dependent manner
(Fig. 3a). In cells treated with 10 or 25 μg/ml of
detoxified CRP for 24 h, compared to the control,
Cx43 protein was reduced respectively by 46% and
53% (for each of the two groups, both p<0.05). Such
a downregulation of CRP is even greater after 72 h of
treatment (decrement, 10 μg/ml, 70%; 25 μg/ml,
82%; both p<0.01, see Fig. 3b). To clarify the effect
of NaN3, HAEC were treated with NaN3 at different
concentrations and the cells exhibited a similar pattern
of Cx43 downregulation (decrement, 100 μM, 51%;
200 μΜ, 60%; both p<0.05, see Fig. 3c). Semiquan-
titative RT-PCR analysis for cells treated with 25 μg/
ml of different preparations of CRP and/or NaN3 for
72 h showed that the Cx43 transcripts were down-
regulated (Fig. 4). In addition, a variety of other
molecules were also downregulated by the detoxified
Fig. 3 Downregulation of
Cx43 expression by detoxi-
fied CRP and NaN3. See
text for details. HAEC were
treated with detoxified CRP
and NaN3 at indicated times
and concentrations. The
histograms show that the
expression levels of Cx43
are attenuated in cells
treated with 10 or 25 μg/ml
detoxified CRP and 100 or
200 μM NaN3. Compared
to the control, *p<0.05
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CRP (Fig. 4), including growth factors related genes
(Flt-1, KDR, and VEGF), angiogenesis factors (Ang1
and Ang2), coagulatory factor (PAI-1), vasodilatory
enzyme (eNOS), adhesion molecules (ICAM and
P-Sel), and other endothelial connexins (Cx37 and
Cx40). Such changes were not seen in cells treated
with detoxified dialyzed CRP. Addition of NaN3 to
the detoxified dialyzed CRP-treated cells resumed the
downregulation, though to a mild extent, in which the
groups of KDR, Ang1, Ang2, and PAI-1 reached
statistical significance (p<0.01, compared to the
detoxified CRP). The downregulation was also seen
in cells treated with NaN3. Dialysis did not fully
abolish the downregulating effects of NaN3 on KDR,
Ang1, Ang2, and PAI-1. However, compared to
HAEC treated with detoxified dialyzed CRP, only
Fig. 4 Transcriptional regulation of HAEC by different
preparations of CRP and/or NaN3, as revealed by semiquanti-
tative RT-PCR. See text for details. Note that for all examined
molecules, except VCAM, treatment with each of CRP/Det,
CRP/Det/Dia + NaN3, and NaN3 resulted in reduction of
transcripts, compared to the control group (all p<0.005). *p<
0.05; #p<0.01
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the mRNA levels of KDR and PAI-1 were lower in
the cells treated with dialyzed NaN3 (both p<0.01).
These endothelial markers, except VCAM, were all
significantly reduced at the mRNA level in cells
treated with each of CRP/Det, CRP/Det/Dia+NaN3,
and NaN3, compared to the control group (all p<
0.05). On the other hand, the levels of VCAM
transcripts remained stationary in response to the
different preparations of CRP and/or NaN3 (Fig. 4).
At the protein level, the direction of change for
Cx43 was consistent with those seen at the transcript
level, as shown in Fig. 5, in which both the
phosphorylated and dephosphorylated forms of Cx43
are reduced by each of detoxified CRP and NaN3, but
not by either the dialyzed NaN3 or detoxified dialyzed
CRP (Fig. 5b). In addition, such changes of the Cx43
protein affected the gap junctional communication
function, as shown by scrap loading/dye transfer
assay (Fig. 6), in which the normal communication
function (Fig. 6a) was impaired to a similar extent in
cells treated with either detoxified CRP (Fig. 6b) or
NaN3 (Fig. 6c), but remained stationary for 48 h in
cells with detoxified dialyzed CRP (Fig. 6d) or
dialyzed NaN3 (Fig. 6e). Prolonged treatment for
72 h with detoxified dialyzed CRP (Fig. 6f) or
dialyzed NaN3 (Fig. 6e) also did not show any
impairment.
Discussion
This study clarifies the effect of CRP on endothelial
Cx43 gap junctions. With a careful design of the
experiments, including electrophoretic confirmation
of the pentameric conformation of CRP, different
preparations of the CRP plus NaN3, and functional
test of the detoxified dialyzed CRP by the ability to
induce IL-8, we unequivocally showed that at both
the mRNA and protein levels, detoxified dialyzed
CRP at a concentration up to 25 μg/ml had a minimal
effect on endothelial Cx43 gap junctions, while
detoxified CRP downregulated the junctions in a
dose-dependent manner. In addition, the effects of
detoxified CRP on Cx43 resembled those of NaN3.
Furthermore, addition of NaN3 to detoxified dialyzed
CRP downregulated the junctions to an extent
equivalent to that of detoxified CRP. Apart from
Cx43, a similar pattern of effects of the different
preparations of CRP and NaN3 were also seen for
mRNA of a variety of other endothelial molecules,
including growth factors related genes (Flt-1, KDR,
and VEGF), angiogenesis factors (Ang1 and Ang2),
coagulatory factor (PAI-1), vasodilatory enzyme
(eNOS), and adhesion molecules (ICAM and P-Sel).
In contrast, VCAM was minimally affected. All these
Fig. 5 Protein expression levels of Cx43. See text for details. a
Representative data. b The histograms showed that total forms
and phosphorylated forms of Cx43 are downregulated in cells
treated with either detoxified CRP or undialyzed NaN3
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findings indicate the importance of preparatory
procedures for studying the in vitro effect of CRP, in
particular, removal of NaN3 by dialysis is a key
procedure and demonstrate that NaN3 has differential
effects on endothelial molecules.
The finding of Cx43 in this study is different from
that of a previous study investigating the same issue
in human umbilical vein endothelial cells. In that
study, Cx43 proteins were not detected but the mRNA
was found to have an about twofold increase in cells
incubated in 10 μg/ml detoxified CRP for 24 h.
Comparison of both studies revealed that the CRP and
detoxification column used were purchased from the
same companies. However, in that study, the detox-
ified CRP was not dialyzed prior to the incubation
with the cells. Other studies examining the direct
effects of CRP in cultured cells showed significant
effects of CRP, including upregulation of PAI-1
(Devaraj et al. 2003, 2006), P-Sel (Yaron et al.
2006), and VCAM-1 (Kawanami et al. 2006) and
downregulation of eNOS (Venugopal et al. 2002,
2003; Devaraj et al. 2003). In these studies, the source
and preparation for human CRP varied, including (a)
detoxified dialyzed recombinant CRP, which was
purchased from the same company and prepared in
the same way as mentioned in the present study
(Devaraj et al. 2006), (b) recombinant CRP from the
same company without mention of dialysis (Kawa-
nami et al. 2006), and (c) both recombinant CRP
generated by a different company without mention of
preparation and CRP-containing sera of C57BL/6
mice transgenic for the human CRP gene (Yaron et al.
2006). Although the findings of these studies seem
different from our results, it should be noted that cells,
treatment dose and period, examination timing, and
transcripts or proteins checked, are not the same. The
purpose that we checked the mRNA levels of other
nongap junctional molecules in the present study is to
examine whether the contribution of NaN3 to Cx43
exists for other molecules, as mentioned by other
Fig. 6 Evaluation of gap
junction communication
function in HAEC treated
with different preparations
of CRP and/or NaN3. Note
that the function is inhibited
by either detoxified CRP or
undialyzed NaN3, but not
by detoxified plus dialyzed
CRP or dialyzed NaN3. Bar,
200 μm
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authors that downregulation of eNOS by the com-
mercial CRP is due to the added NaN3 (Liu et al.
2005; Taylor et al. 2005). On the other hand, at the
presence of a high concentration of NaN3, cells were
dying and many genes may therefore be downregu-
lated due to the toxic effect of NaN3. In addition, gap
junctional communication between cultured cells has
been reported to vary according to the properties of
the surfaces where the cells attached (Banach et al.
2000). Therefore, CRP or NaN3 may have different
effects on gap junctional communication if both
agents were tested in cells grown on different
surfaces.
One interesting finding from the present study is that
some endothelial molecules are extremely sensitive to
NaN3. Even after extensive dialysis against 2,000-fold
sample volume for three times at 4°C within 24 h, the
dialyzed NaN3 still reduced the transcripts of KDR,
Ang1, Ang2, and PAI-1. On the other hand, addition of
NaN3 to detoxified dialyzed CRP seems to attenuate
the toxic effect of NaN3 on endothelial cells. For
example, in HAEC treated with premixed detoxified
dialyzed CRP and NaN3, KDR, Ang1, and PAI-1 are
less reduced, compared to the cells treated with the
same amount of NaN3. It should be emphasized that
Cx43 gap junctions examined in the present study are
located between endothelial cells. Apart from these
junctions, in vascular wall, Cx43 in endothelial cells
can form gap junctions with Cx43 of the subjacent
smooth muscle cells (myoendothelial junctions). Pre-
vious studies showed that proinflammatory cytokines,
such as tumor necrosis factor (TNF)-α and IL-1β,
selectively inhibit human myoendothelial gap junc-
tional communication in vitro without affecting the
communication between the respective homologous
cell populations (Hu and Cotgreave 1997). Whether
the effect of NaN3 on Cx43 gap junctions between
endothelial cells demonstrated in the present study also
exists for myoendothelial gap junctions or those
between smooth muscle cells, like TNF-α (Mensink
et al. 1995), remain to be defined.
In conclusion, human recombinant CRP at a concen-
tration up to 25 μg/ml does not affect the expression of
Cx43 in HAEC and the gap junctional communication,
while NaN3 downregulates the expression and func-
tion. NaN3 has differential effects on endothelial
molecules and the effects are difficult to get rid of by
dialysis. The information is important for ongoing
research using NaN3 as a preservative.
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